Named on 5 rounds in the feed, most often at Series C and in Biotech.
Rounds from 2019-06-26 to 2026-11-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ansa Biotechnologies A trusted partner for DNA synthesis | Series C Verified against 1 of 21 sources | $71.5M | 2026-11-18 | [ PART ] |
Ansa Biotechnologies A trusted partner for DNA synthesis | Series B Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $54.4M | 2025-10-01 | [ PART ] |
LILA Sciences Advanced AI solutions for scientific research and experimentation. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $235M | 2025-09-15 | [ PART ] |
LILA Sciences Advanced AI solutions for scientific research and experimentation. | Seed Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2025-03-12 | [ PART ] |
Encoded Therapeutics Encoded Therapeutics develops gene therapies targeting genetic disorders, primarily focusing on neurological conditions. | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $104M | 2019-06-26 | [ PART ] |